Clinical Trials - Phase II
Filter News
Found 29,772 articles
-
Exelixis, Inc. Initiates Randomized Phase 2 Clinical Trial Of Cabozantinib Plus Abiraterone In Chemotherapy-Naïve Patients With Metastatic Castration-Resistant Prostate Cancer
12/2/2013
-
InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A Therapeutic Vaccine Used In Combination With Standard Antiretroviral Therapy In Treatment Of HIV-Infection
12/2/2013
-
Data From Final Cohort Of Patients In Patrys Limited Multiple Myeloma Clinical Trial
12/2/2013
-
bluebird bio Announces First Patient Transplanted In Phase 1/2 HGB-205 Study For The Treatment Of Beta-Thalassemia And Sickle Cell Anemia
12/2/2013
-
Medivir AB: HELIX-2, A Phase II All-Oral Combination Study Of Simeprevir, TMC647055 And Samatasvir (IDX719) For The Treatment Of Hepatitis C Has Been Initiated
12/2/2013
-
Portola Pharmaceuticals, Inc. Wins Breakthrough Designation From FDA For Andexanet Alfa (PRT4445*)
11/27/2013
-
FibroGen, Inc. Announces Observations Of Possible Disease Stabilization And Improvement In Interim Analysis Of Phase 2 Study Of FG-3019 As Treatment For Idiopathic Pulmonary Fibrosis
11/27/2013
-
Galapagos NV Announces GSK2586184 JAK1 Molecule Moves Into Phase 2 For Ulcerative Colitis
11/27/2013
-
Merrimack Pharmaceuticals Inc.'s MM-121 Demonstrates Positive Signal In Two Phase 2 Breast Cancer Studies; Stock Up +11.46% At Market Close (November 26, 2013)
11/26/2013
-
Bone Therapeutics Treats First Patients In PREOB® Pivotal Phase IIb/III Trial For The Treatment Of Non-Union Fractures
11/26/2013
-
BioLineRx Ltd. Announces New Positive Results In Phase 2a Trial For Orally Available Inflammatory Bowel Disease Treatment
11/26/2013
-
Burzynski Clinic Presents The Results Of A Phase II Study Of Antineoplastons In Pediatric Recurrent Diffuse Intrinsic Pontine Glioma At The Congress
11/25/2013
-
Progenics Pharmaceuticals, Inc. Relaunching Registrational Trial Of Azedra To Treat Pheochromocytomas
11/25/2013
-
Immune Response BioPharma To Keep U.S. NeuroVax Rights For MS Expects Phase IIb Enrollment Q2 2015
11/25/2013
-
Burzynski Clinic Presents The Successful Treatment Of A Child With Recurrent Diffuse Intrinsic Pontine Gliosarcoma At The Congress
11/25/2013
-
Heat Biologics Successfully Completes Manufacturing Of HS-410 To Start Phase 1/2 Bladder Cancer Trial
11/25/2013
-
Cerecor Inc. Receives Fast Track Designation For CERC-301 For The Treatment Of Major Depressive Disorder
11/25/2013
-
Burzynski Clinic Presents The Results Of Phase II Study Of Antineoplastons In Children With Recurrent High-Grade Glioma At The Congress
11/25/2013
-
Burzynski Clinic Presents The Results Of A Phase II Study Of Antineoplastons In Adult Patients With Recurrent Glioblastoma Multiforme At The Congress
11/25/2013
-
Arrowhead Research Corporation Submits Application To Begin Phase 2a Trial Of ARC-520 For The Treatment Of Chronic Hepatitis B Infection
11/25/2013